We’re sorry, something doesn't seem to be working properly.
Please try refreshing the page. If that doesn't work, please contact support so we can address the problem.
References
Uruno T, Kebebew E. How to localize parathyroid tumors in primary hyperparathyroidism? J Endocrinol Invest 2006, 29: 840–
Coakley AJ, Kettle AG, Wells CP, O’Doherty MJ, Collings REC. 99mTc-sestamibi — a new agent for parathyroid imaging. Nucl Med Commun 1989, 10: 791–4.
Taillefer R, Boucher Y, Potvin C, Lambert R. Detection and localization of parathyroid adenomas in patients with hyperparathyroidism using a single radionuclide imaging procedure with technetium-99m-Sestamibi (double-phase study). J Nucl Med 1992; 33: 1801–7.
Mariani G., Gulec SA, Rubello D, et al. Preoperative localization and radioguided parathyroid surgery. J Nucl Med 2003, 44: 1443–58.
Sfakianakis GN, Irvin GL, Foss J, Mallin W, Georgiou M, Deriso GT, et al. Efficient parathyroidectomy guided by SPECTMIBI and hormonal measurements. J Nucl Med 1996, 37: 798–804.
Carty SE, Worsey MJ, Virji MA, Brown ML, Watson CG. Concise parathyroidectomy: the impact of preoperative STECT 99mTc sestamibi scanning and intraoperative quick parathyroid hormone assay. Surgery 1997, 122: 1107–16.
Rubello D, Pelizzo MR, Casara D. Nuclear medicine and minimally invasive surgery of parathyroid adenomas: a fair marriage (editorial). Eur J Nucl Med 2002, 30: 189–92.
Moka D, Voth E, Dietlein M, Larena-Avellaneda A, Schica H. Technetium 99m-MIBI-SPECT: A highly sensitive diagnostic tool for localization of parathyroid adenomas. Surgery 2000, 128: 29–35.
O’Doherty MJ, Kettle AG, Wells P, Collins REC, Coakley AJ. Parathyroid imaging with technetium-99m-Sestamibi: preoperative localization and tissue uptake studies. J Nucl Med 1992, 33: 313–8.
Rubello D, Saladini G, Casara D, Piotto A, Toniato A, Pelizzo MR. Parathyroid imaging with pertechnetate plus perchlorate/MIBI subtraction scintigraphy. A fast and effective technique. Clin Nucl Med 2000, 25: 527–31.
Rubello D, Pelizzo MR, Boni G, et al. Radioguided surgery of primary hyperparathyroidism using the low-dose 99mTc-sestamibi protocol: multiistitutional experience from the Italian Study Group on Radioguided Surgery and Immunoscintigraphy (GISCRIS). J Nucl Med 2005, 46: 220–6.
Rubello D, Fig LM, Casara D, et al. Radioguided Surgery of parathyroid adenomas and recurrent thyroid cancer using the ‘Low Sestamibi Dose’ protocol. Cancer Biother 2006 June issue (in press), 2006
Rubello D, Massaro A, Cittadin S, et al. Role of Sestamibi-SPECT in accurate selection of primary hyperparathyroidism patients for minimally invasive radio-guided surgery. Eur J Nucl Med Mol Imaging DOI: 10.1007/s00259-006-0162-y
Spanu A, Falchi A, Manca A, et al. The usefulness of neck pinhole SPECT as a complementary tool to planar scintigraphy in primary and secondary hyperparathyroidism. J Nucl Med 2004, 45: 40–8.
Gayed IW, Kim EE, Broussard WF, et al. The value of 99mTc-sestamibi SPECT/CT over conventional SPECT in the evaluation of parathyroid adenomas or hyperplasia. J Nucl Med 2005, 46: 248–52.
Author information
Authors and Affiliations
About this article
Cite this article
Rubello, D. How should the “optimal” pre-operative localizing imaging work-up in hyperparathyroid patients be?. J Endocrinol Invest 29, 854–856 (2006). https://doi.org/10.1007/BF03347384
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03347384